ChapARone: No-code Augmented Reality CMS with location-based WebAR/AR for Stations

ChapARone:无代码增强现实 CMS,具有基于位置的 WebAR/AR 站点

基本信息

  • 批准号:
    10089927
  • 负责人:
  • 金额:
    $ 37.24万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Collaborative R&D
  • 财政年份:
    2023
  • 资助国家:
    英国
  • 起止时间:
    2023 至 无数据
  • 项目状态:
    未结题

项目摘要

ChapARone is an end-to-end Augmented Reality accessibility tool, to help disabled passengers when travelling by train. It starts with a user-friendly no-code Content Management Platform which means station staff can upload and control information, all around the station, at the click of a button. And it ends with the passenger getting information all over the station. So now, you don't have to watch the Information board to check for delays or changes to platforms -- all that information will be available by accessing a web of multiple AR-points, and Accessible QR codes, in every part of the station.It's designed to improve accessibility for people with disabilities, but it'll make travel more convenient, more pleasurable for everyone. Passengers will be able to access AR moments station-wide, on their own smartphones, to trigger location-relevant information, fun activities and way-finding facilitation. The AR might be pop-up texts, videos, infographics, or even a companion avatar, to mediate the rail-journey for you, give information, or even interact with fun stories.And the brilliant and unique thing is that station staff can change any of this AR content easily, in near-real-time, thanks to our proprietary AR Content-Management-System. This system gives clients control - think of it like a no-code solution for AR.Creating and changing the AR content couldn't be easier. It's web-based -- using all major browsers. It's really intuitive - Content can be updated by anyone, needing no technical ability. It's no harder than filling in boxes and copy-and-pasting links.So stations can turn their own data-sets, or any non-AR information, into AR-content to make travel for disabled people less stressful and more enjoyable.For instance, station staff could use the system to add AR content about:1. Platforms -- way-finding graphical layouts of the platforms, which are visually engaging,2. Trains -- passengers can engage with layout, seating, facilities etc3. Time-tables -- can be updated4. Delays -- notifications with live delay information.5. Hospitality information -- where to locate refreshments, toilets, help desks, meeting points, lifts etc.This project won't just benefit disabled passengers, it will bring financial stability and added revenue to the railway industry, bringing many more passengers back to train travel, through improved customer experience. And it will empower station staff to communicate easily with their passengers. Now Augmented Reality can support disabled passengers, and indeed all passengers, to make travel so much easier and more enjoyable.
ChapARone是一款端到端的增强现实辅助工具,旨在帮助残疾乘客乘坐火车旅行。它从一个用户友好的无代码内容管理平台开始,这意味着车站工作人员只需点击一个按钮就可以上传和控制车站周围的信息。最后,乘客在车站里到处打听消息。所以现在,你不必再去看信息板来查看站台的延误或变化--所有的信息都可以通过访问一个由多个AR点和可识别的QR码组成的网络来获得,这些点和QR码分布在车站的每个部分。它的设计是为了改善残疾人的无障碍环境,但它会让每个人的旅行更方便,更愉快。乘客将能够在自己的智能手机上访问整个车站的AR时刻,以触发与位置相关的信息,有趣的活动和寻路便利。AR可以是弹出文本、视频、信息图表,甚至是一个同伴化身,为您提供铁路旅行、信息,甚至与有趣的故事互动。而最出色和独特的是,由于我们专有的AR内容管理系统,车站工作人员可以近实时地轻松更改任何AR内容。这个系统为客户提供了控制权-可以把它想象成一个AR的无代码解决方案。它是基于网络的--使用所有主要的浏览器。它非常直观-任何人都可以更新内容,不需要任何技术能力。因此,车站可以将自己的数据集或任何非AR信息转化为AR内容,使残疾人的旅行更轻松,更愉快。例如,车站工作人员可以使用该系统添加以下内容的AR内容:1.平台--平台的寻路图形布局,视觉上是直观的; 2.火车-乘客可以参与布局,座位,设施等3。时间表-可以更新4.延迟--实时延迟信息通知。5.酒店信息-在哪里找到茶点,厕所,服务台,会议点,电梯等。该项目不仅有利于残疾乘客,它将带来金融稳定和增加收入的铁路行业,使更多的乘客回到火车旅行,通过改善客户体验。它将使车站工作人员能够轻松地与乘客沟通。现在,增强现实可以支持残疾乘客,甚至所有乘客,使旅行变得更加轻松和愉快。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

其他文献

吉治仁志 他: "トランスジェニックマウスによるTIMP-1の線維化促進機序"最新医学. 55. 1781-1787 (2000)
Hitoshi Yoshiji 等:“转基因小鼠中 TIMP-1 的促纤维化机制”现代医学 55. 1781-1787 (2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
LiDAR Implementations for Autonomous Vehicle Applications
  • DOI:
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
生命分子工学・海洋生命工学研究室
生物分子工程/海洋生物技术实验室
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
吉治仁志 他: "イラスト医学&サイエンスシリーズ血管の分子医学"羊土社(渋谷正史編). 125 (2000)
Hitoshi Yoshiji 等人:“血管医学与科学系列分子医学图解”Yodosha(涉谷正志编辑)125(2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Effect of manidipine hydrochloride,a calcium antagonist,on isoproterenol-induced left ventricular hypertrophy: "Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,K.,Teragaki,M.,Iwao,H.and Yoshikawa,J." Jpn Circ J. 62(1). 47-52 (1998)
钙拮抗剂盐酸马尼地平对异丙肾上腺素引起的左心室肥厚的影响:“Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:

的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('', 18)}}的其他基金

An implantable biosensor microsystem for real-time measurement of circulating biomarkers
用于实时测量循环生物标志物的植入式生物传感器微系统
  • 批准号:
    2901954
  • 财政年份:
    2028
  • 资助金额:
    $ 37.24万
  • 项目类别:
    Studentship
Exploiting the polysaccharide breakdown capacity of the human gut microbiome to develop environmentally sustainable dishwashing solutions
利用人类肠道微生物群的多糖分解能力来开发环境可持续的洗碗解决方案
  • 批准号:
    2896097
  • 财政年份:
    2027
  • 资助金额:
    $ 37.24万
  • 项目类别:
    Studentship
A Robot that Swims Through Granular Materials
可以在颗粒材料中游动的机器人
  • 批准号:
    2780268
  • 财政年份:
    2027
  • 资助金额:
    $ 37.24万
  • 项目类别:
    Studentship
Likelihood and impact of severe space weather events on the resilience of nuclear power and safeguards monitoring.
严重空间天气事件对核电和保障监督的恢复力的可能性和影响。
  • 批准号:
    2908918
  • 财政年份:
    2027
  • 资助金额:
    $ 37.24万
  • 项目类别:
    Studentship
Proton, alpha and gamma irradiation assisted stress corrosion cracking: understanding the fuel-stainless steel interface
质子、α 和 γ 辐照辅助应力腐蚀开裂:了解燃料-不锈钢界面
  • 批准号:
    2908693
  • 财政年份:
    2027
  • 资助金额:
    $ 37.24万
  • 项目类别:
    Studentship
Field Assisted Sintering of Nuclear Fuel Simulants
核燃料模拟物的现场辅助烧结
  • 批准号:
    2908917
  • 财政年份:
    2027
  • 资助金额:
    $ 37.24万
  • 项目类别:
    Studentship
Assessment of new fatigue capable titanium alloys for aerospace applications
评估用于航空航天应用的新型抗疲劳钛合金
  • 批准号:
    2879438
  • 财政年份:
    2027
  • 资助金额:
    $ 37.24万
  • 项目类别:
    Studentship
Developing a 3D printed skin model using a Dextran - Collagen hydrogel to analyse the cellular and epigenetic effects of interleukin-17 inhibitors in
使用右旋糖酐-胶原蛋白水凝胶开发 3D 打印皮肤模型,以分析白细胞介素 17 抑制剂的细胞和表观遗传效应
  • 批准号:
    2890513
  • 财政年份:
    2027
  • 资助金额:
    $ 37.24万
  • 项目类别:
    Studentship
CDT year 1 so TBC in Oct 2024
CDT 第 1 年,预计 2024 年 10 月
  • 批准号:
    2879865
  • 财政年份:
    2027
  • 资助金额:
    $ 37.24万
  • 项目类别:
    Studentship
Understanding the interplay between the gut microbiome, behavior and urbanisation in wild birds
了解野生鸟类肠道微生物组、行为和城市化之间的相互作用
  • 批准号:
    2876993
  • 财政年份:
    2027
  • 资助金额:
    $ 37.24万
  • 项目类别:
    Studentship

相似海外基金

No-code platform to understand and connect to any Insurance API increasing efficency in the insurance industry
无代码平台可理解并连接到任何保险 API,从而提高保险行业的效率
  • 批准号:
    10037656
  • 财政年份:
    2023
  • 资助金额:
    $ 37.24万
  • 项目类别:
    Collaborative R&D
SBIR Phase I: Super High Performance No-Code Platform
SBIR第一期:超高性能无代码平台
  • 批准号:
    2212675
  • 财政年份:
    2023
  • 资助金额:
    $ 37.24万
  • 项目类别:
    Standard Grant
Extending Zinia no-code AI platform for Streaming AI and Hyper Explainability for SME lenders to optimize price of credit for sub-prime customers, enabling safe and fair access to credit, meeting the growing demand from households crushed by the pandemic
扩展 Zinia 无代码人工智能平台,为中小企业贷方提供流式人工智能和超可解释性,以优化次级贷款客户的信贷价格,实现安全和公平的信贷获取,满足受疫情影响的家庭不断增长的需求
  • 批准号:
    10024287
  • 财政年份:
    2022
  • 资助金额:
    $ 37.24万
  • 项目类别:
    Collaborative R&D
An innovative no-code platform for the creation of conversational AI powered chatbots for high quality customer support, resolving 80% of customer support queries more effectively
An%20innovative%20no-code%20platform%20for%20the%20creation%20of%20conversational%20AI%20powered%20chatbots%20for%20high%20quality%20customer%20support,%20resolving%2080%%20of%20customer%20support%20queries%
  • 批准号:
    10029381
  • 财政年份:
    2022
  • 资助金额:
    $ 37.24万
  • 项目类别:
    Collaborative R&D
Arithmix: A no-code multi-dimensional data aggregation tool utilising novel user access controls to permit secure, collaborative, cross organisational analytics
Arithmix:一种无代码多维数据聚合工具,利用新颖的用户访问控制来允许安全、协作、跨组织分析
  • 批准号:
    10034178
  • 财政年份:
    2022
  • 资助金额:
    $ 37.24万
  • 项目类别:
    Collaborative R&D
SBIR Phase I: No-code electric grid analytics platform for predictive maintenance planning and emergency response
SBIR 第一阶段:用于预测性维护规划和应急响应的无代码电网分析平台
  • 批准号:
    2136505
  • 财政年份:
    2021
  • 资助金额:
    $ 37.24万
  • 项目类别:
    Standard Grant
Recombineering-based no-cleavage gene-editing toolkit for large-scale genome engineering and functional screening
基于重组工程的无切割基因编辑工具包,用于大规模基因组工程和功能筛选
  • 批准号:
    10622585
  • 财政年份:
    2021
  • 资助金额:
    $ 37.24万
  • 项目类别:
ASSESSMENT OF POTENTIAL SUBSTANCE ABUSE TREATMENT MEDICATIONS IN NONHUMAN PRIMATE MODELS. NIDA REF. NO. N01DA-19-8946; POP: 12/16/2018-12/15/2020.
在非人类灵长类动物模型中评估潜在的药物滥用治疗药物。
  • 批准号:
    10788187
  • 财政年份:
    2018
  • 资助金额:
    $ 37.24万
  • 项目类别:
ASSESSMENT OF POTENTIAL SUBSTANCE ABUSE TREATMENT MEDICATIONS IN NONHUMAN PRIMATE MODELS. NIDA REF. NO. N01DA-19-8946; POP: 12/16/2018-12/15/2020.
在非人类灵长类动物模型中评估潜在的药物滥用治疗药物。
  • 批准号:
    10285326
  • 财政年份:
    2018
  • 资助金额:
    $ 37.24万
  • 项目类别:
IGF::OT::IGF ASSESSMENT OF POTENTIAL SUBSTANCE ABUSE TREATMENT MEDICATIONS IN NONHUMAN PRIMATE MODELS. NIDA REF. NO. N01DA-19-8946; POP: 12/16/2018-12/15/2019. PURPOSE: TO EXERCISE OPTION QUANTITIES 1
IGF::OT::IGF 对非人类灵长类动物模型中潜在药物滥用治疗药物的评估。
  • 批准号:
    10551131
  • 财政年份:
    2018
  • 资助金额:
    $ 37.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了